With escalating healthcare costs, changes to the regulatory control on pharmaceutical industries and the inevitable adjustments made in policies and investment in healthcare there is enormous interest in the commercial as well as the scientific aspects of today's healthcare industry. The SAGE Handbook of Healthcare provides an authoritative analysis of the current (and anticipated) developments in the global healthcare industries. Providing a unique perspective that interfaces between the science and business aspects, it combines information on the latest scientific developments with applied, commercial business data from the global marketplace. The Handbook focuses on the aspects of paramount importance in the healthcare sector: - Pharmacoeconomics - Pharmacogenomics - Therapeutics - Diagnostics Areas covered include: - The role of nanotechnology, genomics and cell therapy in medicine - Diagnostics; Biomarkers and technological advances - Case studies in oncology and cardiovascular and CNS therapeuticsThe possibility that patients who enter the coverage gap will limit, or even discontinue, drug therapy to cut costs is a ... Figure 5.5 shows that 79% of patients younger than 65 had private insurance, 10% qualified for Medicare ( primarily on the ... usually administered by intramuscular injection in the physiciana#39;s office) but not the subcutaneously injectable agents Rebif, ... multiple sclerosis therapies simply as aimmunomodulatorsa a a very broad pharmacologic class that includes, withoutanbsp;...
|Title||:||The SAGE Handbook of Healthcare|
|Author||:||Decision Resources Inc|
|Publisher||:||SAGE - 2008-05-22|